We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $27.1B
1-Year Est. Return 20.2%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.18%
AUM
$3.19B
AUM Growth
+$153M
Cap. Flow
+$17.6M
Cap. Flow %
0.55%
Top 10 Hldgs %
29.55%
Holding
324
New
11
Increased
97
Reduced
113
Closed
9

Top Buys

Rank Stock Value
1
RNG icon
RingCentral
RNG
+$27.5M
2
BSX icon
Boston Scientific
BSX
+$25.3M
3
LW icon
Lamb Weston
LW
+$6.07M
4
ADSK icon
Autodesk
ADSK
+$5.95M
5
FCFS icon
FirstCash
FCFS
+$5.8M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$34.4M
2
BKNG icon
Booking.com
BKNG
+$22.2M
3
WEC icon
WEC Energy
WEC
+$7.17M
4
MS icon
Morgan Stanley
MS
+$4.67M
5
INTC icon
Intel
INTC
+$4.26M

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Financials 20.16%
3 Healthcare 11.15%
4 Consumer Staples 11.15%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATI icon
226
ATI
ATI
$26.9B
$504K 0.02%
20,000
LHX icon
227
L3Harris
LHX
$55.4B
$492K 0.02%
2,600
PEN icon
228
Penumbra
PEN
$12.4B
$480K 0.02%
3,000
AU icon
229
AngloGold Ashanti
AU
$39.6B
$476K 0.01%
26,733
-20,000
-43% -$268K
TCMD icon
230
Tactile Systems Technology
TCMD
$621M
$458K 0.01%
8,050
TGI
231
DELISTED
Triumph Group
TGI
$458K 0.01%
20,000
CHTR icon
232
Charter Communications
CHTR
$15.5B
$453K 0.01%
1,146
-100
-8% -$37.5K
BTI icon
233
British American Tobacco
BTI
$128B
$447K 0.01%
12,815
+2,760
+27% +$105K
VXF icon
234
Vanguard Extended Market ETF
VXF
$30.2B
$445K 0.01%
3,750
-200
-5% -$23.4K
BUD icon
235
AB InBev
BUD
$155B
$434K 0.01%
4,900
EMF
236
Templeton Emerging Markets Fund
EMF
$318M
$434K 0.01%
28,755
IONS icon
237
Ionis Pharmaceuticals
IONS
$9.23B
$432K 0.01%
6,720
-1,680
-20% -$119K
GILD icon
238
Gilead Sciences
GILD
$162B
$410K 0.01%
6,070
+523
+9% +$34.4K
LVS icon
239
Las Vegas Sands
LVS
$30.5B
$398K 0.01%
6,739
+380
+6% +$23.5K
HMSY
240
DELISTED
HMS Holdings Corp.
HMSY
$395K 0.01%
12,200
MSON
241
DELISTED
Misonix Inc
MSON
$394K 0.01%
15,500
CCK icon
242
Crown Holdings
CCK
$12.4B
$386K 0.01%
6,310
ALB icon
243
Albemarle
ALB
$13.7B
$385K 0.01%
5,475
APC
244
DELISTED
Anadarko Petroleum
APC
$384K 0.01%
5,440
-190
-3% -$12.7K
AABA
245
DELISTED
Altaba Inc
AABA
$383K 0.01%
5,520
-6,750
-55% -$472K
EWG icon
246
iShares MSCI Germany ETF
EWG
$1.48B
$380K 0.01%
13,538
-5,300
-28% -$148K
LKQ icon
247
LKQ Corp
LKQ
$6.32B
$378K 0.01%
14,200
-2,500
-15% -$70K
EXEL icon
248
Exelixis
EXEL
$13.9B
$374K 0.01%
17,500
STWD icon
249
Starwood Property Trust
STWD
$6.04B
$373K 0.01%
16,400
-130
-0.8% -$2.95K
TVRD
250
Tvardi Therapeutics
TVRD
$24.3M
$366K 0.01%
472

Similar funds

Rathbones Group's Q2 2019 Portfolio in Review

As of Q2 2019, Rathbones Group held 324 positions worth $3.19B, up 5% from $3.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Rathbones Group's Q2 2019 filing shows 11 new, 97 increased, 113 reduced and 9 closed positions. Its largest new stake was RingCentral: 238,300 shares worth $27.4M. The largest sale was Abiomed Inc, an estimated $34.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Rathbones Group's largest Q2 2019 buy was RingCentral: 238,300 shares worth $27.4M.
  • Rathbones Group added most to Boston Scientific in Q2 2019, an estimated $25.3M increase.
  • Rathbones Group's biggest Q2 2019 reduction was Abiomed Inc, cutting an estimated $34.4M.
  • Rathbones Group fully exited Goldcorp Inc in Q2 2019, selling an estimated $461K.
  • Rathbones Group's ten largest holdings make up 30% of its $3.19B portfolio in Q2 2019.
  • Rathbones Group opened 11 new positions and closed 9 in Q2 2019.
  • Rathbones Group's portfolio value rose 5% quarter-over-quarter to $3.19B.

Based on Rathbones Group's 13F filing for Q2 2019, filed 12 Aug 2019.